Product Description
please call me , to know more
AI Product Description
*The following content is generated by AI and is for reference only.
Ofloxacin is a broad-spectrum fluoroquinolone antibiotic widely utilized in clinical settings to treat a diverse array of bacterial infections. Chemically, it belongs to the second generation of fluoroquinolones and functions by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes required for DNA replication, transcription, repair, and recombination. This mechanism effectively halts bacterial growth and leads to cell death. The molecular formula of Ofloxacin is C18H20FN3O4, reflecting its complex structure which includes a fluorine atom at the 6-position and a piperazine ring, features that significantly enhance its antimicrobial potency compared to earlier generations. Its unique CAS registry number is 82419-36-1, serving as a definitive identifier for regulatory, pharmaceutical, and research purposes globally.
Clinically, Ofloxacin demonstrates efficacy against both Gram-positive and Gram-negative organisms, making it a versatile choice for treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain sexually transmitted diseases caused by susceptible bacteria. It is particularly noted for its excellent bioavailability when administered orally, allowing for convenient outpatient treatment protocols alongside intravenous options for severe cases. The drug is commonly available under various brand names, including Floxin, though generic formulations are now predominant due to patent expirations. While highly effective, medical professionals must remain vigilant regarding potential adverse effects, such as tendonitis, peripheral neuropathy, and central nervous system disturbances, which are characteristic class effects of fluoroquinolones. Furthermore, the emergence of bacterial resistance necessitates prudent prescribing practices to preserve its therapeutic value. As a critical component of modern antimicrobial therapy, Ofloxacin continues to play a vital role in managing infectious diseases worldwide, balancing potent bactericidal activity with a well-characterized safety profile when used according to established guidelines. Its structural modifications have optimized pharmacokinetic properties, ensuring adequate tissue penetration for treating deep-seated infections.